Applied Therapeutics Inc.

APLTCIK 0001697532 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Apr 15, 2025. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0155

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Feb 3, 2026no items parsed Dec 12, 2025no items parsed Nov 20, 2025no items parsed Nov 13, 2025no items parsed Aug 29, 2025no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Applied Therapeutics Inc.

Name	Roles	Filings
Skyler Jay S	Director	5
Marcus Joel S	Director	4
Hooks Corwin Dale	Officer	3
Bailey Evan Prescott	Officer	2
Mahadevan Chids	Officer	2

Showing 11-15 of 18

Per pagePrevPage 3 of 4Next

All filings

89 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Feb 4, 2026	Kanter Stacy J. Director	DDisposition	22,500	-	-

Filed		Top transaction	Shares	Price	Value